Health Care & Life Sciences » Pharmaceuticals | Sinovac Biotech Ltd.

Sinovac Biotech Ltd. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
107,242.00
91,518.00
65,460.00
65,441.00
115,964.00
177,078
Total Accounts Receivable
31,927.00
40,757.00
39,021.00
49,832.00
66,205.00
77,463
Inventories
14,329.00
18,832.00
18,655.00
14,102.00
19,618.00
25,091
Other Current Assets
3,610.00
2,591.00
5,358.00
4,864.00
2,101.00
4,543
Total Current Assets
157,108.00
153,698.00
128,494.00
134,239.00
203,888.00
284,175
Net Property, Plant & Equipment
68,671.00
69,804.00
64,241.00
67,846.00
76,958.00
71,390
Intangible Assets
772.00
352.00
-
-
-
-
Other Assets
14,025.00
14,161.00
9,599.00
8,818.00
9,053.00
8,417
Total Assets
240,693.00
238,530.00
202,927.00
211,355.00
299,219.00
369,780
ST Debt & Current Portion LT Debt
19,541.00
49,970.00
24,245.00
33,583.00
18,152.00
Accounts Payable
6,063.00
3,164.00
1,715.00
1,834.00
6,780.00
Income Tax Payable
1,757.00
1,101.00
1,643.00
3,178.00
8,862.00
Other Current Liabilities
21,796.00
25,599.00
30,535.00
27,669.00
58,749.00
Total Current Liabilities
49,157.00
79,834.00
58,138.00
66,264.00
92,543.00
Long-Term Debt
32,146.00
1,803.00
756.00
9,448.00
21,919.00
Deferred Taxes
117.00
515.00
593.00
452.00
9,320.00
Other Liabilities
11,005.00
482.00
2,798.00
3,024.00
3,143.00
Total Liabilities
92,308.00
82,119.00
61,692.00
78,736.00
117,605.00
Common Equity (Total)
128,684.00
126,564.00
121,653.00
115,767.00
151,152.00
Total Shareholders' Equity
128,684.00
126,564.00
121,653.00
115,767.00
151,152.00
Total Equity
143,639.00
141,726.00
136,505.00
129,666.00
177,140.00
Liabilities & Shareholders' Equity
240,693.00
238,530.00
202,927.00
211,355.00
299,219.00
Accumulated Minority Interest
14,955.00
15,162.00
14,852.00
13,899.00
25,988.00
Non-Equity Reserves
4,746.00
14,685.00
4,730.00
2,953.00
4,474.00

About Sinovac Biotech

View Profile
Address
No. 15 Zhi Tong Road
Beijing Beijing 102200
China
Employees -
Website http://www.sinovacbio.com
Updated 07/08/2019
Sinovac Biotech Ltd. is a holding and biopharmaceutical company, which engages in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease. It operates through the Mainland China and Hong Kong geographical segments. Its product pipelines include Healive, Bilive, Anflu, PANFLU.